Laurence Marton

Omniox, Inc. operates as a biopharmaceutical company which develops medicines for hypoxic diseases. Its technology overcomes fundamental biochemical shortcomings of hemoglobin-based and per fluorocarbon oxygen delivery approaches. The company was founded in 2006 by Stephen P. L. Cary, Michael A. Marletta, Jonathan Winger and Elizabeth Marshall Boon and is headquartered in San Carlos, CA.

American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY.

Progen Pharmaceuticals, Inc. researches and develops pharmaceuticals to treat cancer. The company is headquartered in Cary, NC.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

Assurance Health Services, Inc. provides healthcare services. The company is headquartered in Houston, TX.

Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX.

Matternet, Inc. develops drones for its delivery vans. It offers Matternet M2, a drone logistics system that features automatic payload and battery exchange, intelligent routing and monitoring, precision landing, and intuitive command and control. The company was founded by Andreas Raptopoulos, Darlene Damn, Dimitar Pachov, and Paola Santana in 2011 and is headquartered in Menlo Park, CA.

Wavemaker Three-Sixty Health (Wavemaker 360) is an independent private equity/venture capital firm founded in 2018 by John G. Nackel. The firm is headquartered in Pasadena, California.

xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.

NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA.

Cellsonics, Inc. engages in development of a next generation single cell isolation. The company is headquartered in Newark, DE.

Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY.

Enable Medicine, Inc. is a company that aims to make biology more searchable. The company is based in Menlo Park, CA. The company has generated and indexed over a petabyte of data and are studying over 20 diseases across 75 scientific studies. The company works with researchers at institutions worldwide to develop scientific and clinical insights to better understand complex biology. The company's goal is to index and map biology to guide therapeutics discovery and development. The company was founded by Aaron Mayer. The CEO is Sunil Bodapati.

Cancer Commons is a non-profit organization that provides compassionate support for people with advanced or metastatic cancer. The private company is based in Palo Alto. The American company's services include leading-edge care navigation and personalized action plan creation for people with advanced or metastatic cancer. Founded in 2012, the company works one-on-one with patients and caregivers to surface the best-possible action plan for anyone dealing with advanced cancer.